Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2020

Publisher Name :
Date: 01-Jan-2020
No. of pages: 95
Inquire Before Buying

Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.

Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.

USA is the largest consumption place, with a consumption market share nearly 33.14% in 2016. Following USA, Europe is the second largest consumption place with the consumption market share of 23.66%.Market competition is intense. Johnson & Johnson, GSK, Novartis, Pfizer, Valeant PharmaKaken Pharmaceutical are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The global Onychomycosis (Tinea Unguium) Drug market is valued at 2956.3 million US$ in 2020 is expected to reach 3669.4 million US$ by the end of 2026, growing at a CAGR of 3.1% during 2021-2026.

This report focuses on Onychomycosis (Tinea Unguium) Drug volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Onychomycosis (Tinea Unguium) Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Onychomycosis (Tinea Unguium) Drug market is segmented into

- Oral Medication

- External Medicine

Segment by Application

- Age under 18

- Age 18-50

- Age above 50

Global Onychomycosis (Tinea Unguium) Drug Market: Regional Analysis

The Onychomycosis (Tinea Unguium) Drug market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Onychomycosis (Tinea Unguium) Drug market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Onychomycosis (Tinea Unguium) Drug Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Onychomycosis (Tinea Unguium) Drug market include:

- Johnson and Johnson

- GSK

- Novartis

- Pfizer

- Valeant Pharma

- Kaken Pharmaceutical

- Galderma

- Xiuzheng Pharmaceutical

- Letai

- Qilu Pharmaceutical

Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2020

Table of Contents
1 Onychomycosis (Tinea Unguium) Drug Market Overview
1.1 Product Overview and Scope of Onychomycosis (Tinea Unguium) Drug
1.2 Onychomycosis (Tinea Unguium) Drug Segment by Type
1.2.1 Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Oral Medication
1.2.3 External Medicine
1.3 Onychomycosis (Tinea Unguium) Drug Segment by Application
1.3.1 Onychomycosis (Tinea Unguium) Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Age under 18
1.3.3 Age 18-50
1.3.4 Age above 50
1.4 Global Onychomycosis (Tinea Unguium) Drug Market Size Estimates and Forecasts
1.4.1 Global Onychomycosis (Tinea Unguium) Drug Revenue 2015-2026
1.4.2 Global Onychomycosis (Tinea Unguium) Drug Sales 2015-2026
1.4.3 Onychomycosis (Tinea Unguium) Drug Market Size by Region: 2020 Versus 2026
2 Global Onychomycosis (Tinea Unguium) Drug Market Competition by Manufacturers
2.1 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Onychomycosis (Tinea Unguium) Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Onychomycosis (Tinea Unguium) Drug Manufacturing Sites, Area Served, Product Type
2.5 Onychomycosis (Tinea Unguium) Drug Market Competitive Situation and Trends
2.5.1 Onychomycosis (Tinea Unguium) Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Onychomycosis (Tinea Unguium) Drug Players (Opinion Leaders)
3 Onychomycosis (Tinea Unguium) Drug Retrospective Market Scenario by Region
3.1 Global Onychomycosis (Tinea Unguium) Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Onychomycosis (Tinea Unguium) Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Onychomycosis (Tinea Unguium) Drug Market Facts & Figures by Country
3.3.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Country
3.3.2 North America Onychomycosis (Tinea Unguium) Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Onychomycosis (Tinea Unguium) Drug Market Facts & Figures by Country
3.4.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Country
3.4.2 Europe Onychomycosis (Tinea Unguium) Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region
3.5.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Onychomycosis (Tinea Unguium) Drug Market Facts & Figures by Country
3.6.1 Latin America Onychomycosis (Tinea Unguium) Drug Sales by Country
3.6.2 Latin America Onychomycosis (Tinea Unguium) Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Country
3.7.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Onychomycosis (Tinea Unguium) Drug Historic Market Analysis by Type
4.1 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
4.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2015-2020)
4.3 Global Onychomycosis (Tinea Unguium) Drug Price Market Share by Type (2015-2020)
4.4 Global Onychomycosis (Tinea Unguium) Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Onychomycosis (Tinea Unguium) Drug Historic Market Analysis by Application
5.1 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
5.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2015-2020)
5.3 Global Onychomycosis (Tinea Unguium) Drug Price by Application (2015-2020)
6 Company Profiles and Key Figures in Onychomycosis (Tinea Unguium) Drug Business
6.1 Johnson and Johnson
6.1.1 Corporation Information
6.1.2 Johnson and Johnson Description, Business Overview and Total Revenue
6.1.3 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Johnson and Johnson Products Offered
6.1.5 Johnson and Johnson Recent Development
6.2 GSK
6.2.1 GSK Onychomycosis (Tinea Unguium) Drug Production Sites and Area Served
6.2.2 GSK Description, Business Overview and Total Revenue
6.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 GSK Products Offered
6.2.5 GSK Recent Development
6.3 Novartis
6.3.1 Novartis Onychomycosis (Tinea Unguium) Drug Production Sites and Area Served
6.3.2 Novartis Description, Business Overview and Total Revenue
6.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Novartis Products Offered
6.3.5 Novartis Recent Development
6.4 Pfizer
6.4.1 Pfizer Onychomycosis (Tinea Unguium) Drug Production Sites and Area Served
6.4.2 Pfizer Description, Business Overview and Total Revenue
6.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Pfizer Products Offered
6.4.5 Pfizer Recent Development
6.5 Valeant Pharma
6.5.1 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Production Sites and Area Served
6.5.2 Valeant Pharma Description, Business Overview and Total Revenue
6.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Valeant Pharma Products Offered
6.5.5 Valeant Pharma Recent Development
6.6 Kaken Pharmaceutical
6.6.1 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production Sites and Area Served
6.6.2 Kaken Pharmaceutical Description, Business Overview and Total Revenue
6.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Kaken Pharmaceutical Products Offered
6.6.5 Kaken Pharmaceutical Recent Development
6.7 Galderma
6.6.1 Galderma Onychomycosis (Tinea Unguium) Drug Production Sites and Area Served
6.6.2 Galderma Description, Business Overview and Total Revenue
6.6.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Galderma Products Offered
6.7.5 Galderma Recent Development
6.8 Xiuzheng Pharmaceutical
6.8.1 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production Sites and Area Served
6.8.2 Xiuzheng Pharmaceutical Description, Business Overview and Total Revenue
6.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Xiuzheng Pharmaceutical Products Offered
6.8.5 Xiuzheng Pharmaceutical Recent Development
6.9 Letai
6.9.1 Letai Onychomycosis (Tinea Unguium) Drug Production Sites and Area Served
6.9.2 Letai Description, Business Overview and Total Revenue
6.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Letai Products Offered
6.9.5 Letai Recent Development
6.10 Qilu Pharmaceutical
6.10.1 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Production Sites and Area Served
6.10.2 Qilu Pharmaceutical Description, Business Overview and Total Revenue
6.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Qilu Pharmaceutical Products Offered
6.10.5 Qilu Pharmaceutical Recent Development
7 Onychomycosis (Tinea Unguium) Drug Manufacturing Cost Analysis
7.1 Onychomycosis (Tinea Unguium) Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug
7.4 Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Onychomycosis (Tinea Unguium) Drug Distributors List
8.3 Onychomycosis (Tinea Unguium) Drug Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Onychomycosis (Tinea Unguium) Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Onychomycosis (Tinea Unguium) Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Onychomycosis (Tinea Unguium) Drug by Type (2021-2026)
10.2 Onychomycosis (Tinea Unguium) Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Onychomycosis (Tinea Unguium) Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Onychomycosis (Tinea Unguium) Drug by Application (2021-2026)
10.3 Onychomycosis (Tinea Unguium) Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Onychomycosis (Tinea Unguium) Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Onychomycosis (Tinea Unguium) Drug by Region (2021-2026)
10.4 North America Onychomycosis (Tinea Unguium) Drug Estimates and Projections (2021-2026)
10.5 Europe Onychomycosis (Tinea Unguium) Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Onychomycosis (Tinea Unguium) Drug Estimates and Projections (2021-2026)
10.7 Latin America Onychomycosis (Tinea Unguium) Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Onychomycosis (Tinea Unguium) Drug Manufacturers Covered in This Study
Table 5. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Onychomycosis (Tinea Unguium) Drug Sales Share by Manufacturers (2015-2020)
Table 7. Global Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Onychomycosis (Tinea Unguium) Drug Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Onychomycosis (Tinea Unguium) Drug Sales Sites and Area Served
Table 11. Manufacturers Onychomycosis (Tinea Unguium) Drug Product Types
Table 12. Global Onychomycosis (Tinea Unguium) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Onychomycosis (Tinea Unguium) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Onychomycosis (Tinea Unguium) Drug as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Onychomycosis (Tinea Unguium) Drug Players
Table 16. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Region (2015-2020)
Table 17. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2015-2020)
Table 18. Global Onychomycosis (Tinea Unguium) Drug Revenue (Million US$) by Region (2015-2020)
Table 19. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2015-2020)
Table 20. North America Onychomycosis (Tinea Unguium) Drug Sales by Country (2015-2020) (K Units)
Table 21. North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country (2015-2020)
Table 22. North America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2015-2020)
Table 24. Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2015-2020) (K Units)
Table 25. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country (2015-2020)
Table 26. Europe Onychomycosis (Tinea Unguium) Drug Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2015-2020)
Table 32. Latin America Onychomycosis (Tinea Unguium) Drug Sales by Country (2015-2020) (K Units)
Table 33. Latin America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country (2015-2020)
Table 34. Latin America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country (2015-2020)
Table 40. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Type (2015-2020)
Table 41. Global Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2015-2020)
Table 42. Global Onychomycosis (Tinea Unguium) Drug Revenue (Million US$) by Type (2015-2020)
Table 43. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2015-2020)
Table 44. Global Onychomycosis (Tinea Unguium) Drug Price (USD/Unit) by Type (2015-2020)
Table 45. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Application (2015-2020)
Table 46. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
Table 47. Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate by Application (2015-2020)
Table 48. Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Corporation Information
Table 49. Johnson and Johnson Description and Business Overview
Table 50. Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Johnson and Johnson Main Product
Table 52. Johnson and Johnson Recent Development
Table 53. GSK Onychomycosis (Tinea Unguium) Drug Corporation Information
Table 54. GSK Corporation Information
Table 55. GSK Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. GSK Main Product
Table 57. GSK Recent Development
Table 58. Novartis Onychomycosis (Tinea Unguium) Drug Corporation Information
Table 59. Novartis Corporation Information
Table 60. Novartis Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Novartis Main Product
Table 62. Novartis Recent Development
Table 63. Pfizer Onychomycosis (Tinea Unguium) Drug Corporation Information
Table 64. Pfizer Corporation Information
Table 65. Pfizer Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Pfizer Main Product
Table 67. Pfizer Recent Development
Table 68. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Corporation Information
Table 69. Valeant Pharma Corporation Information
Table 70. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Valeant Pharma Main Product
Table 72. Valeant Pharma Recent Development
Table 73. Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Corporation Information
Table 74. Kaken Pharmaceutical Corporation Information
Table 75. Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Kaken Pharmaceutical Main Product
Table 77. Kaken Pharmaceutical Recent Development
Table 78. Galderma Onychomycosis (Tinea Unguium) Drug Corporation Information
Table 79. Galderma Corporation Information
Table 80. Galderma Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Galderma Main Product
Table 82. Galderma Recent Development
Table 83. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Corporation Information
Table 84. Xiuzheng Pharmaceutical Corporation Information
Table 85. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Xiuzheng Pharmaceutical Main Product
Table 87. Xiuzheng Pharmaceutical Recent Development
Table 88. Letai Onychomycosis (Tinea Unguium) Drug Corporation Information
Table 89. Letai Corporation Information
Table 90. Letai Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Letai Main Product
Table 92. Letai Recent Development
Table 93. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Corporation Information
Table 94. Qilu Pharmaceutical Corporation Information
Table 95. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Qilu Pharmaceutical Main Product
Table 97. Qilu Pharmaceutical Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Onychomycosis (Tinea Unguium) Drug Distributors List
Table 101. Onychomycosis (Tinea Unguium) Drug Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) Forecast by Type (2021-2026)
Table 106. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Onychomycosis (Tinea Unguium) Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Onychomycosis (Tinea Unguium) Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) Forecast by Application (2021-2026)
Table 110. Global Onychomycosis (Tinea Unguium) Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) Forecast by Region (2021-2026)
Table 112. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Onychomycosis (Tinea Unguium) Drug
Figure 2. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. Oral Medication Product Picture
Figure 4. External Medicine Product Picture
Figure 5. Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application: 2020 VS 2026
Figure 6. Age under 18
Figure 7. Age 18-50
Figure 8. Age above 50
Figure 9. Global Onychomycosis (Tinea Unguium) Drug Market Size 2015-2026 (US$ Million)
Figure 10. Global Onychomycosis (Tinea Unguium) Drug Sales Capacity (K Units) (2015-2026)
Figure 11. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Onychomycosis (Tinea Unguium) Drug Sales Share by Manufacturers in 2020
Figure 13. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Onychomycosis (Tinea Unguium) Drug Revenue in 2019
Figure 15. Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region in 2019
Figure 18. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region in 2019
Figure 20. North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2019
Figure 21. North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country in 2019
Figure 22. U.S. Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2019
Figure 27. Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country in 2019
Figure 28. Germany Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region in 2019
Figure 39. Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region in 2019
Figure 40. China Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2019
Figure 63. Latin America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country in 2019
Figure 64. Mexico Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Country in 2019
Figure 72. Turkey Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Type (2015-2020)
Figure 79. Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Type in 2019
Figure 80. Revenue Share of Onychomycosis (Tinea Unguium) Drug by Type (2015-2020)
Figure 81. Revenue Market Share of Onychomycosis (Tinea Unguium) Drug by Type in 2019
Figure 82. Global Onychomycosis (Tinea Unguium) Drug Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
Figure 84. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Onychomycosis (Tinea Unguium) Drug by Application (2015-2020)
Figure 86. Global Revenue Share of Onychomycosis (Tinea Unguium) Drug by Application in 2020
Figure 87. Johnson and Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Valeant Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Kaken Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Galderma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Xiuzheng Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Letai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Price Trend of Key Raw Materials
Figure 98. Manufacturing Cost Structure of Onychomycosis (Tinea Unguium) Drug
Figure 99. Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug
Figure 100. Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Porter's Five Forces Analysis
Figure 104. North America Onychomycosis (Tinea Unguium) Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 105. North America Onychomycosis (Tinea Unguium) Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Onychomycosis (Tinea Unguium) Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Onychomycosis (Tinea Unguium) Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Onychomycosis (Tinea Unguium) Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Onychomycosis (Tinea Unguium) Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed
  • Global Pruritus Therapeutics Market Growth (Status and Outlook) 2020-2025
    Published: 13-Feb-2020        Price: US 3660 Onwards        Pages: 132
    According to this study, over the next five years the Pruritus Therapeutics market will register a 5.2% CAGR in terms of revenue, the global market size will reach $ 15000 million by 2025, from $ 12250 million in 2019. In particular, this report presents the global revenue market share of key companies in Pruritus Therapeutics business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Pruritus Therapeutics market by type......
  • Global Dermal Fillers Market Growth 2020-2025
    Published: 10-Feb-2020        Price: US 3660 Onwards        Pages: 158
    According to this study, over the next five years the Dermal Fillers market will register a 16.8% CAGR in terms of revenue, the global market size will reach $ 7559.3 million by 2025, from $ 4061 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dermal Fillers business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Dermal Fillers market by type, appli......
  • Global Acne Medication Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 09-Feb-2020        Price: US 3480 Onwards        Pages: 109
    Market Overview The global Acne Medication market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1% in the forecast period of 2020 to 2025 and will expected to reach USD 7718.3 million by 2025, from USD 7098.1 million in 2019. The Acne Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analy......
  • Global Pruritus Therapeutics Market Data Survey Report 2015-2025
    Published: 09-Feb-2020        Price: US 1500 Onwards        Pages: 59
    Summary Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex. The global Pruritus Therapeutics market will reach xxx Million......
  • Prescription Dermatological Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 140
    Prescription Dermatological Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Prescription Dermatological Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Prescription Dermatological Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight......
  • Psoriasis Therapeutic Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 147
    Psoriasis Therapeutic Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Psoriasis Therapeutic industry with a focus on the Chinese market. The report provides key statistics on the market status of the Psoriasis Therapeutic manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese ......
  • Cosmetic Surgery and Service Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 136
    Cosmetic Surgery and Service Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cosmetic Surgery and Service industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cosmetic Surgery and Service manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-202......
  • Skin Disease Treatment Technologies Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 149
    Skin Disease Treatment Technologies Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Skin Disease Treatment Technologies industry with a focus on the Chinese market. The report provides key statistics on the market status of the Skin Disease Treatment Technologies manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-dept......
  • Vasculitis Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 08-Feb-2020        Price: US 3000 Onwards        Pages: 139
    Vasculitis Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Vasculitis Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Vasculitis Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Vasculitis Drug ma......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs